{
    "title": "106_hr1039",
    "content": "SECTION 1. CREDIT FOR CLINICAL TESTING RESEARCH EXPENSES ATTRIBUTABLE TO CERTAIN QUALIFIED ACADEMIC INSTITUTIONS INCLUDING TEACHING HOSPITALS. This section introduces a new credit for medical innovation expenses under the Internal Revenue Code of 1986. The medical innovation credit under section 38 allows for a 20 percent credit on qualified medical innovation expenses exceeding the medical innovation base period amount. Qualified expenses include payments to qualified academic institutions for clinical testing research activities before product approval. The medical innovation credit provides a 20 percent credit on qualified expenses for clinical testing research activities conducted at qualified academic institutions before product approval. The medical innovation credit offers a 20 percent credit on qualified expenses for clinical testing research activities at qualified academic institutions, which include educational institutions, teaching hospitals, and medical research organizations affiliated with these institutions. The medical innovation credit excludes expenses funded by grants or contracts. The medical innovation base period amount is the average annual qualified expenses in the three years before the first taxable year after December 31, 1998. Special rules apply. The medical innovation credit excludes expenses funded by grants or contracts. Special rules apply, such as the limitation on foreign testing and the election requirement for taxpayers to apply this section for a taxable year. Coordination with other research expenditure credits is also specified. The medical innovation credit excludes expenses funded by grants or contracts and has special rules like limiting foreign testing and requiring taxpayers to elect this section for a taxable year. The credit is part of the general business credit under section 38(b) of the Code, and there is no carryback of the credit before a specified date. The medical innovation credit under section 41A of the Code prohibits carryback of unused credits before January 1, 1999. Additionally, no deduction is allowed for qualified medical innovation expenses equal to the credit determined under section 41A(a). The deduction for the unused portion of the medical innovation expenses credit under section 41A(a) is subject to certain rules similar to those in subsection (c). The Code is amended to include the medical innovation expenses credit in the definition of qualified business credits. A clerical amendment is made to the table of sections for subpart D of part IV of subchapter A of chapter 1 of the Code. The amendments made by this section regarding the credit for medical innovation expenses apply to taxable years starting after December 31, 1998."
}